Comparison of T2-weighted and contrast-enhanced T1-weighted MR imaging at 1.5 T for assessing the local extent of cervical carcinoma

Akita, Ayano; Shinmoto, Hiroshi; Hayashi, Shigenori; Akita, Hirotaka; Fujii, Takuma; Mikami, Shuji; Tanimoto, Akihiro; Kuribayashi, Sachio

doi:10.1007/s00330-011-2122-6

Cited by 30 publications

(18 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…While DCE-MRI is currently optional with newly diagnosed cervical cancer, it improves tumor-to-cervical stromal contrast in patients with small tumors (<2 cm), which is useful in patients being considered for fertility preservation (33, 37). DCE-MRI is essential for local staging of endometrial cancer and for characterization of adnexal lesions (27, 38).…”

Section: Part Iii: Suggested Tailored Mri Protocols For the Initial Wmentioning

confidence: 99%

“…On DWI, the tumor has high SI on high-b-value images and low SI on ADC maps relative to the cervical stroma (62). While DCE-MRI is not required for initial staging, small tumors may enhance earlier than adjacent stroma with most tumors being iso or hypointense on delayed images (37, 63, 64). …”

Section: Part Iv: Fertility-sparing Management Of Cervical Cancermentioning

confidence: 99%

“…Prior procedures can lead to overestimation secondary to edema, inflammation, and granulation tissue. The addition of DWI and DCE-MRI to T2WI may increase tumor conspicuity and aid the detection/size assessment of small tumors (32, 35, 37, 68). …”

Section: Part Iv: Fertility-sparing Management Of Cervical Cancermentioning

confidence: 99%

“…Thus, MRI can identify high-risk patients who may have a better chance at fertility preservation if managed with neoadjuvant chemotherapy plus conservative surgery approach. The addition of DWI and DCE-MRI to T2WI can aid the assessment of endocervical extent through enhanced conspicuity of tumor margins (32, 35, 37). …”

Section: Part Iv: Fertility-sparing Management Of Cervical Cancermentioning

confidence: 99%

See 3 more Smart Citations

Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management

et al. 2017

View full text Add to dashboard Cite

Historically, cancer treatment has emphasized measures for the “cure” regardless of the long-term consequences. Advances in cancer detection and treatment have resulted in improved outcomes bringing to the fore various quality of life considerations including future fertility. For many young cancer patients, fertility preservation is now an integral component of clinical decision-making and treatment design. Optimal fertility-sparing options for young patients with gynecologic cancer are influenced by patient age, primary cancer, treatment regimens, and patient preferences. Possible approaches include embryo or oocyte cryopreservation, ovarian transposition, conservative surgery, and conservative medical treatment to delay radical surgery. These may be used alone or in combination to maximize fertility preservation. Awareness of the various fertility-sparing options, eligibility criteria, and the central role of Magnetic Resonance Imaging (MRI) in the proper selection of patients will enable radiologists to produce complete clinically relevant imaging reports and serve as effective consultants to referring clinicians. Knowledge of the potential imaging pitfalls is essential to avoid misinterpretation and guide appropriate management.

show abstract

Section: Part Iii: Suggested Tailored Mri Protocols For the Initial Wmentioning

confidence: 99%

Section: Part Iv: Fertility-sparing Management Of Cervical Cancermentioning

confidence: 99%

Section: Part Iv: Fertility-sparing Management Of Cervical Cancermentioning

confidence: 99%

Section: Part Iv: Fertility-sparing Management Of Cervical Cancermentioning

confidence: 99%

See 2 more Smart Citations

Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management

et al. 2017

View full text Add to dashboard Cite

show abstract

“…Evaluation of the earlier phases of contrast enhancement may help to accurately delineate small cervical tumors [ 47 ] . The use of intravenous contrast medium is also recognized as helpful in the posttreatment setting, to differentiate residual or recurrent tumor from radiation fibrosis [ 6 ] .…”

Section: Cervical Cancermentioning

confidence: 99%

Gynecologic tumors: how to communicate imaging results to the surgeon

et al. 2013

View full text Add to dashboard Cite

Gynecologic cancers are a leading cause of morbidity and mortality for female patients, with an estimated 88,750 new cancer cases and 29,520 deaths in the United States in 2012. To offer the best treatment options to patients it is important that the radiologist, surgeon, radiation oncologist, and gynecologic oncologist work together with a multidisciplinary approach. Using the available diagnostic imaging modalities, the radiologist must give appropriate information to the surgeon in order to plan the best surgical approach and its timing.

show abstract

Cervical Cancer

Collettini¹,

Hamm²

2017

MRI and CT of the Female Pelvis

View full text Add to dashboard Cite

Comparison of T2-weighted and contrast-enhanced T1-weighted MR imaging at 1.5 T for assessing the local extent of cervical carcinoma

Abstract: Contrast-enhanced T1-weighted imaging is more useful for assessing cervical carcinoma than T2-weighted imaging.

Cited by 30 publications

References 26 publications

Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management

Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management

Gynecologic tumors: how to communicate imaging results to the surgeon

Cervical Cancer

Contact Info

Product

Resources

About